Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Immunoglobulin and Serum Components in Recurrent Miscarriage
ChiCTR2500106801Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of immune globulin in recurrent miscarriage (RPL), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Serological markers. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
immune globulin
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on ChiCTR2500106801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106801.